Small cell carcinoma of the lung surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 8: Line 8:
==Surgery==
==Surgery==
* Surgery should only be considered among patients with clinical stage I (T1-2, N0).  Given that the majority of patients are not diagnosed with clinical stage I (T1-2, N0), surgery is rarely performed among SCCL patients.
* Surgery should only be considered among patients with clinical stage I (T1-2, N0).  Given that the majority of patients are not diagnosed with clinical stage I (T1-2, N0), surgery is rarely performed among SCCL patients.
* Before a patient is considered for [[lobectomy]], investigation for occult nodal involvement by either [[mediastinoscopy]] or mediatinal node dissection should be performed.
* Before a patient is considered for surgical resection of the tumor, investigation for occult nodal involvement by either [[mediastinoscopy]] or mediastinal node dissection should be performed.
* Post-operative palliative treatment following [[lobectomy]] is the following:
* Post-operative palliative treatment following surgery includes:
** [[Small cell carcinoma of the lung medical therapy|Chemotherapy]] if there is no nodal involvement
** [[Small cell carcinoma of the lung medical therapy|Chemotherapy]] if there is no nodal involvement
** [[Small cell carcinoma of the lung medical therapy|Chemotherapy]] PLUS [[small cell carcinoma of the lung radiation therapy|radiation therapy]] if there is nodal involvement
** [[Small cell carcinoma of the lung medical therapy|Chemotherapy]] PLUS [[small cell carcinoma of the lung radiation therapy|radiation therapy]] if there is nodal involvement
** Prophylactic cranial irradiation is recommended among patients who underwent complete resection of the tumor if their performance status is good and if they do not have any neurological cognitive impairment.


==References==
==References==

Revision as of 16:26, 8 June 2014

Small Cell Carcinoma of the Lung Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Small Cell Carcinoma of the Lung from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Radiation Therapy

Surgery

Prevention

Future or Investigational Therapies

Case Studies

Case #1

Small cell carcinoma of the lung surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Small cell carcinoma of the lung surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Small cell carcinoma of the lung surgery

CDC on Small cell carcinoma of the lung surgery

Small cell carcinoma of the lung surgery in the news

Blogs on Small cell carcinoma of the lung surgery

Directions to Hospitals Treating Small cell carcinoma of the lung

Risk calculators and risk factors for Small cell carcinoma of the lung surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

In small cell carcinoma of the lung (SCCL), surgery should only be considered among patients with clinical stage I (T1-2, N0). Postoperative chemotherapy with or without radiation therapy is recommended based on the presence or absence of lymph node involvement.

Surgery

  • Surgery should only be considered among patients with clinical stage I (T1-2, N0). Given that the majority of patients are not diagnosed with clinical stage I (T1-2, N0), surgery is rarely performed among SCCL patients.
  • Before a patient is considered for surgical resection of the tumor, investigation for occult nodal involvement by either mediastinoscopy or mediastinal node dissection should be performed.
  • Post-operative palliative treatment following surgery includes:
    • Chemotherapy if there is no nodal involvement
    • Chemotherapy PLUS radiation therapy if there is nodal involvement
    • Prophylactic cranial irradiation is recommended among patients who underwent complete resection of the tumor if their performance status is good and if they do not have any neurological cognitive impairment.

References


Template:WikiDoc Sources